Fig. 7
From: A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
Neutralizing titers of 26 human sera against Akata-EBV-GFP virus infection of epithelial cells determined by FCM and HCIS. A Neutralizing titers of 26 human sera determined by FCM. Data was shown as mean ± SEM (n = 2). Curves were fit using four parameters nonlinear regression. B Neutralizing titers of 26 human sera determined by HCIS. Data was shown as mean ± SEM (n = 2). Curves were fit using four parameters nonlinear regression. C Half maximal neutralizing dilution fold (ND50) of 26 human sera determined by FCM and HCIS. Horizontal lines represent mean ± SEM. D Correlation of half maximal neutralizing dilution fold (ND50) defined between FCM and HCIS